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Sanjay Rajagopalan, MD,y Robert D. Brook, MDzI ndoor and outdoor air pollution rank as thefourth and ninth leading causes of globalmorbidity and mortality in the most recent
Global Burden of Disease (GBD) report and collec-
tively outrank other major risk factors in terms of
importance (1). The ﬁne particulate matter <2.5 mm
(PM2.5) component of inhaled particulate matter,
more than other larger fractions, dominates risk
through its impact on cardiovascular events (2).
A substantial body of evidence supports a stereotypic
activation of adverse mechanisms, including height-
ened inﬂammation, vascular dysfunction, autonomic
imbalance, and enhanced thrombosis in response to
air pollution exposure (2). Interestingly, these same
mechanisms also potentiate other chronic diseases
(e.g., atherosclerosis, hypertension, and diabetes),
and thus, may contribute to a much larger attribut-
able risk from pollution than previously appreciated.
Although indoor air pollution from combustion of
biomass fuels including wood, charcoal, crop resi-
dues, and dried animal dung continues to remain a
stubborn consequence of economics in many parts
of the world, in the large industrial megacities of
China, outdoor sources of air pollution, including
coal power generation, automobile exhaust, and in-
dustrial entities dominate (3,4). Daily outdoor air
pollution levels in many major cities in Asia, such as
Beijing, Shanghai, and Wuhan, often exceed 100 to
500 mg/m3. Recent data derived from satellite based
measurements of air quality in East Asia are sobering*Editorials published in the Journal of the American College of Cardiology
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contents of this paper to disclose.and point to an increase in the proportion of
patients in East Asia living above the World Health
Organization (WHO) interim Target-1 of 35 mg/m3
(increased from 51% in 1998 to 2000 to 70% in
2010 to 2012) (5). In stark contrast in North America,
the vast majority of the population lives below the
WHO Air Quality standard of 10 mg/m3, with 20%
exposed to PM2.5 above this level (5). However, in-
dividuals living within regions meeting air quality
standards can still face health risks posed by
“hot spots” of exposure (e.g., near roadways, point
sources of emissions).
Studies of air pollution have traditionally focused
on exclusive outdoor and indoor domains for reasons
relating to the nature of pollutants, sources, and
populations exposed. This dichotomization is irrele-
vant in cities in China and India, where outdoor air
pollution has an outsized effect on indoor levels.
Given the fact that individuals in most societies spend
a substantive amount of times indoors, considerable
exposure to air pollution may occur in this setting.
Improving outdoor air quality has been a Sisyphean
task in Asia, with short-term improvements being
overshadowed by an inexhaustible appetite for cheap
power and automobile use. The indoor environment in
contrast to outdoor air pollution can be controlled.
The evidence to date on the impact of improving
indoor air quality has been mostly from the West
using air puriﬁers to improve pollutants attributable
to speciﬁc sources at relatively lower levels (5 to 50
mg/m3) (6–9). An obvious question is whether
reducing much higher levels of indoor air pollution
(50 to 150 mg/m3) also will translate into similar ef-
fects on cardiovascular events and if so, at what
time course?SEE PAGE 2279In this issue of the Journal, Chen et al. (10) publish
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2289double-blind, randomized, cross-over study of an
air ﬁlter intervention >48 h, among 35 healthy young
university students in Shanghai, China. The chosen
location is a strength of the study, being conducted in
a very polluted part of the world, with average levels
of 103 mg/m3. Active air ﬁltration proved capable of
reducing indoor PM2.5 concentration by just more
than one-half, from 96.2 to 41.3 mg/m3. After 48 h of
“cleaner air” exposure, systolic and diastolic blood
pressure fell, whereas a few of the measured metrics
of inﬂammation (MCP-1, interleukin-1b, myeloper-
oxidase) and platelet activation (sCD40L) were
signiﬁcantly reduced. Several other biomarkers also
trended towards improvement, but were not signiﬁ-
cantly changed. Fractional exhaled nitric oxide, an
established marker of respiratory inﬂammation, was
reduced, but lung function measured by spirometry
did not change, possibly owing to the short-term
nature of the intervention. Added to the results
from a few previous studies, these new ﬁndings
bolster the evidence that improving indoor air ﬁltra-
tion may be a practical “personalized” method to
reduce overall PM2.5 exposure and mitigate adverse
health effects. The observed improvement in out-
comes, despite particulate levels remaining high
during air ﬁltration (41.3 mg/m3) supports the pre-
vailing understanding of a log-linear dose–response
relationship between exposure and health effects,
whereby any lowering of pollution can translate into
beneﬁts with larger absolute beneﬁts, the higher the
level of air pollution (2). The population was homo-
geneous, taking no potentially confounding medica-
tions, and residing within 2 nearby buildings, thus
making for a clean study design. Assuming the
participants complied with the protocol, potential
confounding effects of lifestyle changes (e.g., diet,
activity), unmeasured environmental factors (e.g.,
trafﬁc, noise, temperature), and PM2.5 exposure mis-
classiﬁcation(s) were all likely minimized. Most ofthe improved health endpoints also were signi-
ﬁcantly linearly associated with the directly
measured indoor PM2.5 levels across both exposure
scenarios, lending further credence to a prob-
able causal exposure–health response relationship.
Though changes in gaseous pollutants did not likely
confound the main results, as they were thought not
to be altered by ﬁltration, their levels were not
evaluated. It thus remains unclear whether a
concomitant reduction in these copollutants could
provide further or differing health beneﬁts. The spe-
ciﬁc sources (e.g., trafﬁc, coal-ﬁred power plants),
particle sizes (ﬁne vs. ultraﬁne ranges), and compo-
nents (organic/elemental carbon, sulfates, metals)
most strongly linked to the health effects also were
not reported.
Although improvement in outdoor air quality ul-
timately will be needed to change indoor air quality
in the cities of China and India, when rapid changes
in outdoor air quality occur, as it did during the
Beijing Olympics (PM2.5 levels 101 and 84 mg/m3
before and after, averaging 69 mg/m3 during the
games), several biomarkers of inﬂammation throm-
bosis, as well as blood pressure, improved (11). The
good news is that air quality regulations, when
enforced, can substantially reduce prevailing out-
door air pollution concentrations and improve soci-
etal life expectancy rates (12). In the meantime,
personalized behavioral and small-scale inter-
ventions to lower exposures (e.g., ﬁlters in homes
and cars) may be needed in order to optimally protect
citizens in these areas (13).
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